Page last updated: 2024-12-05

1,2,4,5-tetrachlorobenzene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1,2,4,5-Tetrachlorobenzene is a chlorinated aromatic hydrocarbon with the molecular formula C6H2Cl4. It is a white crystalline solid at room temperature. It is used as a precursor in the synthesis of various other chemicals, including pesticides, dyes, and pharmaceuticals. It is also used as a heat transfer fluid and in the production of plastics. It is an environmental pollutant, known to be toxic to aquatic life. It is persistent in the environment and can bioaccumulate in the food chain. Its effects on human health include skin and eye irritation, respiratory problems, and liver damage. Due to its potential environmental and health risks, research focuses on its synthesis, environmental fate, toxicity, and remediation strategies.'
```

1,2,4,5-tetrachlorobenzene : A tetrachlorobenzene carrying chloro groups at positions 1, 2, 4 and 5. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID7270
CHEMBL ID45428
CHEBI ID36697
SCHEMBL ID348913
MeSH IDM0070432

Synonyms (71)

Synonym
AC-20113
AKOS009031577
benzene, 1,2,4,5-tetrachloro-
95-94-3
wln: gr bg dg eg
nsc-27003
1,4,5-tetrachlorobenzene
nsc27003
s-tetrachlorobenzene
DIVK1C_001056
CHEBI:36697 ,
1,2,4,5-tetrachlorbenzol
CDS1_000016
MLS001055490
smr001227186
NCGC00090685-01
1,2,4,5-tetrachlorobenzene
rcra waste number u207
rcra waste no. u207
benzene tetrachloride
brn 1618315
ai3-01835
hsdb 2733
nsc 27003
1,2,4,5-tetrachlorbenzol [russian]
ccris 766
einecs 202-466-2
inchi=1/c6h2cl4/c7-3-1-4(8)6(10)2-5(3)9/h1-2
1,2,4,5-tetrachlorobenzene, analytical standard
1,2,4,5-tetrachlorobenzene, 98%
NCGC00090685-02
MAYBRIDGE1_002304
1,2,4,5-tetrachloro-benzene
CHEMBL45428
HMS548A16
T0060
NCGC00090685-04
NCGC00090685-03
benzene, 1,2,4,5-tetrachloro-, radical ion(1-)
63697-22-3
1,2,4,5-tetrachlorobenzene radical anion
HMS3039K13
unii-66wii99b89
benzene, tetrachloro-
12408-10-5
einecs 235-643-8
66wii99b89 ,
NCGC00259256-01
NCGC00254246-01
tox21_300505
tox21_201707
dtxsid7024320 ,
dtxcid604320
cas-95-94-3
5n27529kgh ,
unii-5n27529kgh
FT-0606240
SCHEMBL348913
1,2,4,5-tetrachlorobenzene [mi]
1,2,4,5-tetrachlorobenzene [hsdb]
W-100149
STL483079
mfcd00000549
1,2,4,5-tetrachlorobenzene, pestanal(r), analytical standard
benzene, 1,2,4,5-tetrachloro-; 1,2,4,5-tetrachlorobenzene; nsc 27003; s-tetrachlorobenzene
1,2,4,5-tetrachlorobenzene 10 microg/ml in cyclohexane
1,2,4,5-tetrachlorobenzene 100 microg/ml in methanol
F21442
Q2557079
AS-13406
EN300-20469

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" It was concluded that, at the dose ranges studied, pretreatment with PB or PCB did not significantly alter the toxic effects produced by TCB."( Effect of phenobarbital and polychlorinated biphenyls on the toxicity and disposition of 1,2,4,5-tetrachlorobenzene in the rat.
Chu, I; Valli, VE; Villeneuve, DC; Yagminas, A, 1986
)
0.49
" Results indicate that 1,2,4,5-TCB is the most toxic isomer of the three and accumulates in liver and fat in a dose-dependent manner."( Toxicity of 1,2,3,4-, 1,2,3,5- and 1,2,4,5-tetrachlorobenzene in the rat: results of a 90-day feeding study.
Chu, I; Secours, VE; Valli, VE; Villeneuve, DC, 1984
)
0.54
" LD50 values for 1,2,3,4-, 1,2,4,5-, and 1,2,3,5-TCB were found to be 1470, 3105, and 2297 mg/kg, respectively, in male rats."( Comparative toxicity of 1,2,3,4-, 1,2,4,5-, and 1,2,3,5-tetrachlorobenzene in the rat: results of acute and subacute studies.
Chu, I; Secours, V; Valli, VE; Villeneuve, D,
)
0.13
" 1,2,4,5-TeCB was neither lethal, nor produced any perceptible adverse effects, at lipid normalized concentrations predicted to be lethal according to the well-established critical body residue concept."( Differential acute toxicity of tetrachlorobenzene isomers to oligochaetes in soil and water: application of the critical body residue concept.
Hurdzan, CM; Lanno, RP; Sovic, DM, 2011
)
0.37

Bioavailability

ExcerptReferenceRelevance
" The sorption, dissipation, and bioavailability of chlorobenzenes (CBs) in soil were investigated."( Immobilization of chlorobenzenes in soil using wheat straw biochar.
Gu, C; Jiang, X; Kengara, FO; Song, Y; Wang, F; Yang, X, 2013
)
0.39

Dosage Studied

ExcerptRelevanceReference
" Five animals per group were killed 2 days after dosing and another five animals were killed 7 days later for the determination of hepatic microsomal enzyme activities, histological changes and 14C-content in the major organs and tissues."( Effect of phenobarbital and polychlorinated biphenyls on the toxicity and disposition of 1,2,4,5-tetrachlorobenzene in the rat.
Chu, I; Valli, VE; Villeneuve, DC; Yagminas, A, 1986
)
0.49
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
tetrachlorobenzeneAny member of the class of chlorobenzenes carrying four chloro groups at unspecified positions.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
1,2,4,5-tetrachlorobenzene degradation48

Protein Targets (5)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
GLI family zinc finger 3Homo sapiens (human)Potency24.33650.000714.592883.7951AID1259369
Smad3Homo sapiens (human)Potency0.10000.00527.809829.0929AID588855
farnesoid X nuclear receptorHomo sapiens (human)Potency28.18380.375827.485161.6524AID588527
estrogen nuclear receptor alphaHomo sapiens (human)Potency57.34520.000229.305416,493.5996AID743069; AID743075; AID743077; AID743079
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency43.27710.000627.21521,122.0200AID743219
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (19)

Assay IDTitleYearJournalArticle
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID162229Toxicity determined using Konemann's Industrial Pollutants Toxicity Test1991Journal of medicinal chemistry, May, Volume: 34, Issue:5
Using theoretical descriptors in quantitative structure-activity relationships: some toxicological indices.
AID289348Biomagnification factors in human2007Science (New York, N.Y.), Jul-13, Volume: 317, Issue:5835
Food web-specific biomagnification of persistent organic pollutants.
AID289347Biomagnification factors in Diporeia2007Science (New York, N.Y.), Jul-13, Volume: 317, Issue:5835
Food web-specific biomagnification of persistent organic pollutants.
AID289345Octanol-water partition coefficient, log KOW of the compound2007Science (New York, N.Y.), Jul-13, Volume: 317, Issue:5835
Food web-specific biomagnification of persistent organic pollutants.
AID289346Octanol-air partition coefficient, log KOA of the compound2007Science (New York, N.Y.), Jul-13, Volume: 317, Issue:5835
Food web-specific biomagnification of persistent organic pollutants.
AID603957Octanol-water partition coefficient, log P of the compound2008European journal of medicinal chemistry, Apr, Volume: 43, Issue:4
QSPR modeling of octanol/water partition coefficient for vitamins by optimal descriptors calculated with SMILES.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (34)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (20.59)18.7374
1990's6 (17.65)18.2507
2000's10 (29.41)29.6817
2010's10 (29.41)24.3611
2020's1 (2.94)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 31.93

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index31.93 (24.57)
Research Supply Index3.64 (2.92)
Research Growth Index4.52 (4.65)
Search Engine Demand Index42.09 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (31.93)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.70%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other36 (97.30%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]